John Somberg to Atrial Fibrillation
This is a "connection" page, showing publications John Somberg has written about Atrial Fibrillation.
Connection Strength
1.429
-
Digoxin therapy for atrial fibrillation in the twenty-first century. Am J Ther. 2014 Sep-Oct; 21(5):325-6.
Score: 0.410
-
The impact of comorbidities on stroke prophylaxis strategies in atrial fibrillation patients. Am J Ther. 2011 Nov; 18(6):510-7.
Score: 0.337
-
The extrapolation of study results in the device approval process. Am J Cardiol. 2009 May 01; 103(9):1323-4.
Score: 0.281
-
Enhancement of myocardial vulnerability by atrial fibrillation. Am J Ther. 2004 Jan-Feb; 11(1):33-43.
Score: 0.196
-
Efficacy of Intravenous and Oral Sotalol in Pharmacologic Conversion of Atrial Fibrillation: A Systematic Review and Meta-Analysis. Cardiology. 2017; 136(1):52-60.
Score: 0.118
-
New advances and new questions in cardiovascular therapeutics. Am J Ther. 2009 Sep-Oct; 16(5):375-7.
Score: 0.073
-
Safety and efficacy of flestolol, a new ultrashort-acting beta-adrenergic blocking agent, for supraventricular tachyarrhythmias. Am J Cardiol. 1986 Nov 01; 58(10):1005-8.
Score: 0.015